Manufacturers will then owe money back to CMS for the difference between the WAC and the negotiated $245 net price
This explains why some patients on GLP-1 therapy may regain weight after stopping their metabolic engine has downshifted due to lean mass loss, not fat
Compounded medications, when prescribed, are prepared for individually identified patients by a state licensed pharmacy and are not FDA approved products
Symptoms are often vague, multi-systemic, and persistent
It can cause swelling anywhere in the body, although it typically affects the face, hands, feet, genitals, or lips
Reductions in muscle volume seem commensurate with what would be expected given the degree of weight loss achieved, and improvements in insulin sensitivity and muscle fat infiltration likely contribute to better muscle quality even when total volume decreases somewhat